As of 2024-12-12, the Fair Value of Sigilon Therapeutics, Inc. (SGTX) is -73.73 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 22.47 USD, the upside of Sigilon Therapeutics, Inc. is -428.14%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -43.93 | -54.61 | -77.31 | -43.56 | -54.85 | |
| YoY growth | -92.93% | -24.31% | -41.57% | 43.65% | -28.79% | |
| Market Cap (mil) | 56.50 |
| P/E | |
| Forward P/E |
| EPS | -14.75 |
| Avg earnings growth rate | -28.79% |
| TTM earnings | -37.08 |